Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 16,500 | |||
5 mg | 在庫あり | ¥ 38,000 | |||
10 mg | 在庫あり | ¥ 57,000 | |||
25 mg | 在庫あり | ¥ 95,500 | |||
50 mg | 在庫あり | ¥ 142,000 | |||
100 mg | 在庫あり | ¥ 201,500 | |||
500 mg | 在庫あり | ¥ 411,000 |
説明 | Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M. |
別名 | AST2818 mesylate |
分子量 | 664.7 |
分子式 | C29H35F3N8O5S |
CAS No. | 2130958-55-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alflutinib mesylate 2130958-55-1 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR cancer Epidermal growth factor receptor AST2818 esistant mutation AST2818 Mesylate Alflutinib AST 2818 Mesylate Alflutinib Mesylate AST-2818 Mesylate AST-2818 Furmonertinib HER1 AST2818 mesylate AST 2818 NSCLC ErbB-1 Inhibitor T790M inhibit inhibitor